Latest news
Loading news…
Psyadon Pharmaceuticals is dedicated to the discovery and development of new treatments for serious psychiatric and neurological diseases.
Psyadon Pharmaceuticals on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Psyadon Pharmaceuticals was acquired by Emalex Biosciences in 2018.
Total Funding
$5.2M
Funding Rounds
1
Last Funding
Acquisitions
0
Monthly Visits
Contacts
0
About Psyadon Pharmaceuticals
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Germantown, Maryland, United States
Psyadon Pharmaceuticals Funding Rounds
1 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–1 of 1Show
Page 1 / 1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Psyadon Pharmaceuticals
Loading news…
FAQs about Psyadon Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.